Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of XC2309 tablets for duodenal ulcer
CTR20261320Phase 3Active
- Sponsor
- Zhejiang Medicine Co., Ltd.
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of XC2309 in duodenal ulcer, sponsored by Zhejiang Medicine Co., Ltd.. Started May 2026; status: active.
02
Drugs
XC2309
03
Conditions
duodenal ulcer
Beyond the preview
Go deeper on CTR20261320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20261320.